MiniMed Group, Inc. (MMED)
NASDAQ: MMED · Real-Time Price · USD
14.23
+0.17 (1.21%)
At close: Jun 5, 2026, 4:00 PM EDT
14.00
-0.23 (-1.62%)
After-hours: Jun 5, 2026, 7:26 PM EDT

Revenue

Millions USD. Fiscal year is May - Apr.
Fiscal Year
FY 2026FY 2025FY 2024FY 2023
Period Ending
Apr '26 Apr '25 Apr '24 Apr '23
Pumps Revenue
546.00M541.00M
Pumps Revenue Growth
0.92%0.18%
Consumables Revenue
956.00M854.00M
Consumables Revenue Growth
11.94%9.91%
Continuous Glucose Monitoring (CGM) Revenue
1.55B1.31B
Continuous Glucose Monitoring (CGM) Revenue Growth
18.28%17.55%
Other Segment Revenue
46.00M6.00M
Other Segment Revenue Growth
666.67%-82.35%
Revenue (Other)
1.00M1.00M
Revenue (Total)
3.10B2.72B
Revenue (Total) Growth
14.25%9.96%

Revenue by Geography

Millions USD. Fiscal year is May - Apr.
Fiscal Year
FY 2026FY 2025FY 2024FY 2023
Period Ending
Apr '26 Apr '25 Apr '24 Apr '23
United States Revenue
917.00M903.00M
United States Revenue Growth
1.55%8.40%
International Revenue
2.19B1.81B
International Revenue Growth
20.59%10.76%
Revenue (Other)
--
Revenue (Total)
3.10B2.72B
Revenue (Total) Growth
14.25%9.96%

Key Performance Indicators

Millions USD. Fiscal year is May - Apr.
Fiscal Year
FY 2026FY 2025FY 2024FY 2023
Period Ending
Apr '26 Apr '25 Apr '24 Apr '23
US - Organic Revenue Growth
1.50%8.40%
International - Organic Revenue Growth
11.20%13.10%
Total Organic Revenue Growth
8.00%11.50%
Updated Jun 3, 2026. Data Source: Fiscal.ai.